|
1.
|
Epps KC and Wilensky RL: Lp-PLA(2)- a
novel risk factor for high-risk coronary and carotid artery
disease. J Intern Med. 269:94–106. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Rubinstein A and Izkhakov E: Lipoprotein
associated phospholipase A2. Harefuah. 150:136–140. 2052011.(In
Hebrew).
|
|
3.
|
Zheng GH, Chen HY, Xiong SQ and Chu JF:
Lipoprotein-associated phospholipase A2 gene V279F polymorphisms
and coronary heart disease: a meta-analysis. Mol Biol Rep.
38:4089–4099. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Ballantyne CM, Hoogeveen RC, Bang H, et
al: Lipoprotein-associated phospholipase A2, high-sensitivity
C-reactive protein, and risk for incident coronary heart disease in
middle-aged men and women in the Atherosclerosis Risk in
Communities (ARIC) study. Circulation. 109:837–842. 2004.
View Article : Google Scholar
|
|
5.
|
Suchindran S, Rivedal D, Guyton JR, et al:
Genome-wide association study of Lp-PLA(2) activity and mass in the
Framingham Heart Study. PLoS Genet. 6:e10009282010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Sandhu MS, Waterworth DM, Debenham SL, et
al: LDL-cholesterol concentrations: a genome-wide association
study. Lancet. 371:483–491. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Assmann G, Schulte H, von Eckardstein A
and Huang Y: High-density lipoprotein cholesterol as a predictor of
coronary heart disease risk. The PROCAM experience and
patho-physiological implications for reverse cholesterol transport.
Atherosclerosis. 124:S11–S20. 1996. View Article : Google Scholar
|
|
8.
|
Gordon T, Castelli WP, Hjortland MC,
Kannel WB and Dawber TR: High density lipoprotein as a protective
factor against coronary heart disease. The Framingham Study. Am J
Med. 62:707–714. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Lim S, Park YM, Sakuma I and Koh KK: How
to control residual cardiovascular risk despite statin treatment:
Focusing on HDL-cholesterol. Int J Cardiol. April 12–2012.(Epub
ahead of print).
|
|
10.
|
Sertic J, Skoric B, Lovric J, Bozina T and
Reiner Z: Does Lp-PLA2 determination help predict atherosclerosis
and cardiocerebrovascular disease? Acta Med Croatica. 64:237–245.
2010.(In Croatian).
|
|
11.
|
Thompson A, Gao P, Orfei L, et al:
Lipoprotein-associated phospholipase A(2) and risk of coronary
disease, stroke, and mortality: collaborative analysis of 32
prospective studies. Lancet. 375:1536–1544. 2010. View Article : Google Scholar
|
|
12.
|
Delgado P, Chacon P, Penalba A, et al:
Lipoprotein-associated phospholipase A(2) activity is associated
with large-artery atherosclerotic etiology and recurrent stroke in
TIA patients. Cerebrovasc Dis. 33:150–158. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Grallert H, Dupuis J, Bis JC, et al: Eight
genetic loci associated with variation in lipoprotein-associated
phospholipase A2 mass and activity and coronary heart disease:
meta-analysis of genome-wide association studies from five
community-based studies. Eur Heart J. 33:238–251. 2012. View Article : Google Scholar
|
|
14.
|
Higgs ZC, Macafee DA, Braithwaite BD and
Maxwell-Armstrong CA: The Seldinger technique: 50 years on. Lancet.
366:1407–1409. 2005.PubMed/NCBI
|
|
15.
|
No authors listed:. Nomenclature and
criteria for diagnosis of ischemic heart disease. Report of the
Joint International Society and Federation of Cardiology/World
Health Organization task force on standardization of clinical
nomenclature. Circulation. 59:607–609. 1979. View Article : Google Scholar
|
|
16.
|
Gabriel S, Ziaugra L and Tabbaa D: SNP
genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc
Hum Genet Chapter 2. Unit 2.12,. 2009. View Article : Google Scholar
|
|
17.
|
Excoffier L and Lischer HE: Arlequin suite
ver 3.5: a new series of programs to perform population genetics
analyses under Linux and Windows. Mol Ecol Resour. 10:564–567.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Sham PC and Curtis D: Monte Carlo tests
for associations between disease and alleles at highly polymorphic
loci. Ann Hum Genet. 59:97–105. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Dupont WD and Plummer WD Jr: Power and
sample size calculations. A review and computer program. Control
Clin Trials. 11:116–128. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Emslie C: Women, men and coronary heart
disease: a review of the qualitative literature. J Adv Nurs.
51:382–395. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Gorelick PB: Lipoprotein-associated
phospholipase A2 and risk of stroke. Am J Cardiol. 101:34F–40F.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Samani NJ, Braund PS, Erdmann J, et al:
The novel genetic variant predisposing to coronary artery disease
in the region of the PSRC1 and CELSR2 genes on chromosome 1
associates with serum cholesterol. J Mol Med (Berl). 86:1233–1241.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Zhou L, Ding H, Zhang X, et al: Genetic
variants at newly identified lipid loci are associated with
coronary heart disease in a Chinese Han population. PLoS One.
6:e274812011. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Casas JP, Ninio E, Panayiotou A, et al:
PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity,
and coronary heart disease risk in 10 494 cases and 15 624 controls
of European Ancestry. Circulation. 121:2284–2293. 2010. View Article : Google Scholar
|
|
25.
|
Sutton BS, Crosslin DR, Shah SH, et al:
Comprehensive genetic analysis of the platelet activating factor
acetylhydrolase (PLA2G7) gene and cardiovascular disease in
case-control and family datasets. Hum Mol Genet. 17:1318–1328.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Li L, Qi L, Lv N, et al: Association
between lipoprotein-associated phospholipase A2 gene polymorphism
and coronary artery disease in the Chinese Han population. Ann Hum
Genet. 75:605–611. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Jang Y, Kim OY, Koh SJ, et al: The
Val279Phe variant of the lipoprotein-associated phospholipase A2
gene is associated with catalytic activities and cardiovascular
disease in Korean men. J Clin Endocrinol Metab. 91:3521–3527. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Jang Y, Waterworth D, Lee JE, et al:
Carriage of the V279F null allele within the gene encoding
Lp-PLA(2) is protective from coronary artery disease in South
Korean males. PLoS One. 6:e182082011. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Willer CJ, Sanna S, Jackson AU, et al:
Newly identified loci that influence lipid concentrations and risk
of coronary artery disease. Nat Genet. 40:161–169. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Naj AC, West M, Rich SS, et al:
Association of scavenger receptor class B type I polymorphisms with
subclinical atherosclerosis: the Multi-Ethnic Study of
Atherosclerosis. Circ Cardiovasc Genet. 3:47–52. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Brautbar A, Covarrubias D, Belmont J, et
al: Variants in the APOA5 gene region and the response to
combination therapy with statins and fenofibric acid in a
randomized clinical trial of individuals with mixed dyslipidemia.
Atherosclerosis. 219:737–742. 2011. View Article : Google Scholar
|
|
32.
|
Waterworth DM, Ricketts SL, Song K, et al:
Genetic variants influencing circulating lipid levels and risk of
coronary artery disease. Arterioscler Thromb Vasc Biol.
30:2264–2276. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Guo L, Song Z, Li M, et al: Scavenger
receptor BI protects against septic death through its role in
modulating inflammatory response. J Biol Chem. 284:19826–19834.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Rodriguez-Esparragon F, Rodriguez-Perez
JC, Hernandez-Trujillo Y, et al: Allelic variants of the human
scavenger receptor class B type 1 and paraoxonase 1 on coronary
heart disease: genotype-phenotype correlations. Arterioscler Thromb
Vasc Biol. 25:854–860. 2005. View Article : Google Scholar
|
|
35.
|
Papp AC, Pinsonneault JK, Wang D, et al:
Cholesteryl Ester Transfer Protein (CETP) polymorphisms affect mRNA
splicing, HDL levels, and sex-dependent cardiovascular risk. PLoS
One. 7:e319302012. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Schierer A, Been LF, Ralhan S, Wander GS,
Aston CE and Sanghera DK: Genetic variation in cholesterol ester
transfer protein, serum CETP activity, and coronary artery disease
risk in Asian Indian diabetic cohort. Pharmacogenet Genomics.
22:95–104. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Smith EN, Chen W, Kahonen M, et al:
Longitudinal genome-wide association of cardiovascular disease risk
factors in the Bogalusa heart study. PLoS Genet. 6:e10010942010.
View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Borggreve SE, Hillege HL, Wolffenbuttel
BH, et al: An increased coronary risk is paradoxically associated
with common cholesteryl ester transfer protein gene variations that
relate to higher high-density lipoprotein cholesterol: a
population-based study. J Clin Endocrinol Metab. 91:3382–3388.
2006. View Article : Google Scholar
|
|
39.
|
Anand SS, Xie C, Pare G, et al: Genetic
variants associated with myocardial infarction risk factors in over
8000 individuals from five ethnic groups: The INTERHEART Genetics
Study. Circ Cardiovasc Genet. 2:16–25. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Yang KC, Su YN, Shew JY, et al: LDLR and
ApoB are major genetic causes of autosomal dominant
hypercholesterolemia in a Taiwanese population. J Formos Med Assoc.
106:799–807. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Ahmed W, Ajmal M, Sadeque A, et al: Novel
and recurrent LDLR gene mutations in Pakistani hypercholesterolemia
patients. Mol Biol Rep. 39:7365–7372. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Slimani A, Jelassi A, Jguirim I, et al:
Effect of mutations in LDLR and PCSK9 genes on phenotypic
variability in Tunisian familial hypercholesterolemia patients.
Atherosclerosis. 222:158–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
